Form 4: Elevance Health Executive Trades Common Stock
Statement of Changes in Beneficial Ownership
Ronald W. Penczek, CAO & Controller of Elevance Health, Inc., reported transactions involving the acquisition and disposition of company common stock and employee stock options on May 19, 2026.
Summary
- Ronald W. Penczek, CAO & Controller of Elevance Health, Inc. (ELV), executed several transactions on May 19, 2026.
- Penczek acquired 654 shares of common stock at $271.27 per share and an additional 877 shares at $311.48 per share.
- He also disposed of 1,531 shares of common stock at a price of $403.13 per share.
- Following these transactions, Penczek beneficially owns 4,109 shares of common stock directly.
- The filing also details the exercise of employee stock options, with 654 options exercised at $271.27 and 877 options exercised at $311.48, both of which were fully vested.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports routine insider transactions related to stock option exercises and sales, without clear indicators of significant positive or negative sentiment towards the company's performance.
Positives
- Acquisition of 1,531 shares of common stock by a key executive, indicating potential confidence in the company's future.
- Exercise of fully vested employee stock options, suggesting that executive compensation plans are being utilized as intended.
Negatives
- Disposition of 1,531 shares of common stock by a key executive, which could be interpreted as a reduction in direct ownership.
Future Outlook
No specific forward-looking statements or guidance were provided in this Form 4 filing.
Industry Context
StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions and do not inherently signal strategic shifts. The reported transactions reflect typical executive compensation plan activity and potential portfolio adjustments.
Stakeholder Impact
- Shareholders: The disposition of shares by an executive may lead to minor market fluctuations or investor scrutiny, though the context of option exercises suggests it may be routine.
- Employees: The exercise of vested stock options by management reinforces the alignment of employee incentives with company performance.
- Management: The transactions reflect the executive's personal financial decisions and compensation realization.
Key Dates
| Date | Description |
|---|---|
| 05/19/2026 | Date of earliest transaction reported and transaction date for stock acquisitions and dispositions, and option exercises. |
| 05/20/2026 | Date of signature on the filing. |
| 03/01/2031 | Expiration date for employee stock options exercised at $311.48. |
| 03/02/2030 | Expiration date for employee stock options exercised at $271.27. |
| 03/25/2026 | Date of acquisition of 10.21 shares through a dividend reinvestment plan, included in balance. |
Keywords
Elevance Health, ELV, Form 4, Insider Trading, Stock Options, Common Stock, Beneficial Ownership, Securities Exchange Act, Ronald W. Penczek
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.